ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Hanyang, Seoul

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Coronavirus Infections
Infections
Post-Acute COVID-19 Syndrome
Human Influenza
Pneumonia
Communicable Diseases
Respiratory Distress Syndrome

COVID-19 trials near Hanyang, Seoul, KOR:

Locations recently updated

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...

Enrolling
COVID-19 Infection
Drug: remdesivir
Drug: placebo for ibuzatrelvir

Phase 3

Pfizer
Pfizer

Seoul, Seoul-teukbyeolsi [seoul], South Korea and 59 other locations

The immunogenicity and safety of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/dose/Vial) administered as a booster in healthy adults aged 19 years old a...

Active, not recruiting
COVID-19
Vaccines
Biological: Comirnaty Bivalent 0.1mg/mL (tozinameran and riltozinameran)
Biological: AdCLD-CoV19-1 OMI

Phase 3

Cellid

Seoul, Korea, Republic of and 16 other locations

legal age for adult in each country) with confirmed mild or moderate COVID-19 tested positive with a real time reverse transcriptio...

Enrolling
COVID-19
Drug: ES16001 80 mg
Drug: ES16001 40 mg

Phase 2, Phase 3

Genencell

Seoul, Korea, Republic of and 2 other locations

Parallel-treatment Group, Adaptive Design, Multi-center, Phase 2b/3 Trial to Evaluate Efficacy and Safety of NuSepin® Intravenous Infusion in COVID...

Enrolling
COVID-19 Pneumonia
Drug: Placebo
Drug: NuSepin® 0.2 mg/kg

Phase 2, Phase 3

Shaperon

Incheon, Namdong-gu, Korea, Republic of

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Seoul, Gyeonggi-do, Korea, Republic of and 66 other locations

The purpose of the study is to evaluate the immunogenicity, reactogenicity, and safety of mRNA-1083 in adults 50 years of age and older in participat...

Active, not recruiting
COVID-19
Influenza
Biological: Licensed Influenza Vaccine
Biological: mRNA-1083

Phase 3

Moderna
Moderna

Seoul, South Korea and 44 other locations

Locations recently updated

The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...

Enrolling
COVID-19 SARS-CoV-2 Infection
Drug: placebo
Drug: ibuzatrelvir

Phase 3

Pfizer
Pfizer

Seoul, Seoul-teukbyeolsi [seoul], South Korea and 201 other locations

Locations recently updated

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Seoul, South Korea and 200 other locations

This study is to evaluate the safety, reactogenicity, and immunogenicity of the QTP104 vaccine against SARS-CoV-2 infection in healthy adults.

Active, not recruiting
COVID-19
SARS-CoV-2
Biological: QTP104 1ug
Biological: QTP104 5ug

Phase 1

Quratis

Seoul, Korea, Republic of and 1 other location

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...

Enrolling
Viral Lung Infection and Acute Respiratory Failure
Drug: Tozorakimab
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Seoul, South Korea and 446 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems